MORPHINE-6-GLUCURONIDE--DEVELOPMENT OF BREATHING CONTROL

吗啡-6-葡萄糖苷酸--呼吸控制的发展

基本信息

  • 批准号:
    2120343
  • 负责人:
  • 金额:
    $ 14.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-12-15 至 1996-11-30
  • 项目状态:
    已结题

项目摘要

The goal of this proposal is to determine the extent and consequence of exposure of the guinea pig fetus and neonate to morphine-6-glucuronide (M6G), an active metabolite of morphine (MOR) and heroin. M6G will be quantitated in fetal and maternal tissues by high-performance liquidchrnmatography after chronic exposure to MOR. Maternal, fetal and neonatal production of M6G from MOR will be examined in hepatic microsomal preparations. The effect of chronic in utero MOR exposure upon neonatal breathing, oxygen consumption and carbon dioxide production will be studied using a noninvasive plethysmographic technique. Neonatal growth will be monitored. The interrelationship of dose, plasma and brain drug concentrations and intensity of respiratory depression will be examined in neonates as a function of age. Breathing effects of morphine-3-glucuronide (M3G), a metabolite of heroin and MOR with activities opposite to those of M6G, and the extent of its formation from MOR will be examined and compared to M6G. Ability of the opiate receptor antagonist naloxone to reverse the breathing depression of M6G will be compared to the hypothesized antagonistic effects of M3G. The guinea pig is an appropriate model for the human perinatal pharmacology of M6G in several respects: the guinea pig produces the glucuronide metabolites of MOR; the breathing response to narcotic drugs and carbon dioxide is similar in the two species; and the guinea pig has a hemomonochorial placenta similar in structure and permeability characteristics to the human placenta. The importance of M6G has only been recognized recently and therefore its fetal and neonatal pharmacology is virtually unknown. Since abuse of narcotic drugs, such as heroin and MOR, during pregnancy is a substantial public health problem in the United States, and in utero exposure to these drugs has been implicated in breathing abnormalities and in an increased incidence of the sudden-infant-death syndrome (SIDS), it is important to understand the pharmacology of active metabolites which may accumulate during pregnancy. The data from this research will be valuable in investigating whether active metabolites of heroin and MOR have a role in the development of neonatal breathing abnormalities some of which may contribute to SIDS, in educating women of child bearing age, and in caring for infants who have had in utero narcotic exposure.
本提案的目标是确定以下方面的程度和后果: 豚鼠胎仔和新生儿暴露于吗啡-6-葡糖苷酸 (M6G)是吗啡(莫尔)和海洛因的活性代谢物。M6 G将是 通过高效液相色谱法在胎儿和母体组织中定量 在慢性暴露于莫尔之后的液相色谱。母体、胎儿和 将在肝微粒体中检查新生儿莫尔产生的M6 G 准备工作宫内慢性莫尔暴露对新生儿的影响 呼吸,氧气消耗和二氧化碳的产生将是 使用非侵入性体积描记技术进行研究。新生儿生长 将受到监控。剂量、血浆和脑药物的相互关系 呼吸抑制的浓度和强度将在 新生儿作为年龄的函数。吗啡-3-葡萄糖醛酸苷的呼吸作用 (M3G)是海洛因和莫尔的代谢产物,活性与 M6 G,以及它从莫尔形成的程度将被检查, 与M6 G相比。阿片受体拮抗剂纳洛酮的能力, 将M6 G的呼吸抑制与 假设M3 G的拮抗作用。豚鼠是一种合适的 M6 G在几个方面的人类围产期药理学模型: 豚鼠产生莫尔的葡糖苷酸代谢物;呼吸 对麻醉药品和二氧化碳的反应在两个国家是相似的 种;和豚鼠有一个血绒膜胎盘类似, 结构和对人胎盘的渗透特性。的 M6 G的重要性直到最近才被认识到,因此它 胎儿和新生儿药理学几乎是未知的。由于滥用 麻醉药物,如海洛因和莫尔,在怀孕期间是一个实质性的 美国的公共卫生问题,以及在子宫内暴露于这些 药物与呼吸异常有关, 婴儿猝死综合征(SIDS)的发病率,重要的是 了解可能累积的活性代谢物的药理学 孕期这项研究的数据将是有价值的, 研究海洛因和莫尔的活性代谢物是否在 新生儿呼吸异常的发展,其中一些可能 为小岛屿发展中国家教育育龄妇女和照顾 在子宫内接触过麻醉剂的婴儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE D OLSEN其他文献

GEORGE D OLSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE D OLSEN', 18)}}的其他基金

DO ENDOGENOUS OPIATES CAUSE INCREASE IN THERMAL PAIN TOLERANCE AFTER MASSAGE?
按摩后内源性阿片类药物会增加热痛耐受性吗?
  • 批准号:
    7206626
  • 财政年份:
    2005
  • 资助金额:
    $ 14.84万
  • 项目类别:
Effects of ginkgo biloba on coagulation
银杏叶对凝血的影响
  • 批准号:
    6465879
  • 财政年份:
    2000
  • 资助金额:
    $ 14.84万
  • 项目类别:
IBUPROFEN AND EPINEPHRINE IN GLOMERULAR FILTRATION
布洛芬和肾上腺素在肾小球滤过中的作用
  • 批准号:
    6116974
  • 财政年份:
    1998
  • 资助金额:
    $ 14.84万
  • 项目类别:
IBUPROFEN AND EPINEPHRINE IN GLOMERULAR FILTRATION
布洛芬和肾上腺素在肾小球滤过中的作用
  • 批准号:
    6278169
  • 财政年份:
    1997
  • 资助金额:
    $ 14.84万
  • 项目类别:
THE EFFECTS OF CIPROFLOXACIN ON THE PHARMACOKINETICS OF CAFFEINE
环丙沙星对咖啡因药代动力学的影响
  • 批准号:
    6248092
  • 财政年份:
    1997
  • 资助金额:
    $ 14.84万
  • 项目类别:
MORTPHINE-6 GLUCURONIDE--DEVELOPMENT OF BREATHING CONTRO
吗啡-6葡萄糖苷酸--呼吸控制的发展
  • 批准号:
    2751432
  • 财政年份:
    1993
  • 资助金额:
    $ 14.84万
  • 项目类别:
MORPHINE-6 GLUCURONIDE--DEVELOPMENT OF BREATHING CONTROL
吗啡-6 葡萄糖苷酸——呼吸控制的发展
  • 批准号:
    6137791
  • 财政年份:
    1993
  • 资助金额:
    $ 14.84万
  • 项目类别:
MORPHINE-6-GLUCURONIDE--DEVELOPMENT OF BREATHING CONTROL
吗啡-6-葡萄糖苷酸--呼吸控制的发展
  • 批准号:
    2120342
  • 财政年份:
    1993
  • 资助金额:
    $ 14.84万
  • 项目类别:
MORPHINE-6-GLUCURONIDE--DEVELOPMENT OF BREATHING CONTROL
吗啡-6-葡萄糖苷酸--呼吸控制的发展
  • 批准号:
    2120344
  • 财政年份:
    1993
  • 资助金额:
    $ 14.84万
  • 项目类别:
Mu Opioid Receptor Regulation in Neonatal Brainstem
新生儿脑干中的 Mu 阿片受体调节
  • 批准号:
    6876474
  • 财政年份:
    1993
  • 资助金额:
    $ 14.84万
  • 项目类别:

相似海外基金

Understanding and Improving Electrochemical Carbon Dioxide Capture
了解和改进电化学二氧化碳捕获
  • 批准号:
    MR/Y034244/1
  • 财政年份:
    2025
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Fellowship
Collaborative Research: Non-Linearity and Feedbacks in the Atmospheric Circulation Response to Increased Carbon Dioxide (CO2)
合作研究:大气环流对二氧化碳 (CO2) 增加的响应的非线性和反馈
  • 批准号:
    2335762
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
CAS: Reductive Functionalization of Carbon Dioxide with Light Olefins
CAS:二氧化碳与轻质烯烃的还原官能化
  • 批准号:
    2349537
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
Collaborative Research: Non-Linearity and Feedbacks in the Atmospheric Circulation Response to Increased Carbon Dioxide (CO2)
合作研究:大气环流对二氧化碳 (CO2) 增加的响应的非线性和反馈
  • 批准号:
    2335761
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
Collaborative Research: EAGER: Energy for persistent sensing of carbon dioxide under near shore waves.
合作研究:EAGER:近岸波浪下持续感知二氧化碳的能量。
  • 批准号:
    2339062
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
Accelerated carbon dioxide release from sedimentary rocks in a warming world
在变暖的世界中沉积岩加速二氧化碳释放
  • 批准号:
    NE/Y000838/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Research Grant
EA/Ed: Acquisition of a carbon dioxide and methane Cavity Ringdown Spectrometer for education and research
EA/Ed:购买二氧化碳和甲烷腔衰荡光谱仪用于教育和研究
  • 批准号:
    2329285
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
The effective and sustainable allocation of the land-based carbon dioxide removal options under changing climate
气候变化下陆基二氧化碳清除方案的有效和可持续分配
  • 批准号:
    24K20979
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New electrodes for green electrochemical carbon dioxide capture
用于绿色电化学二氧化碳捕获的新型电极
  • 批准号:
    DE240100623
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Discovery Early Career Researcher Award
SBIR Phase I: Optimizing Composition of Novel Molten Alkali Metal Borates for Carbon Dioxide Capture
SBIR 第一阶段:优化用于二氧化碳捕获的新型熔融碱金属硼酸盐的成分
  • 批准号:
    2332658
  • 财政年份:
    2024
  • 资助金额:
    $ 14.84万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了